Accepting new patients (614) 430-8022 7965 N High St, Suite 205
Optimed Immunology
Patient Portal Schedule Consultation

What is Dupixent?

Dupixent has the broadest set of FDA-approved indications of any Type 2 biologic — covering asthma, atopic dermatitis, nasal polyps, eosinophilic esophagitis, prurigo nodularis, and COPD. By blocking the IL-4 and IL-13 pathways central to Type 2 inflammation, it can address multiple coexisting conditions with a single therapy.

What it treats

Dupixent is FDA-approved for the following indications:

  • Moderate to severe atopic dermatitis
  • Moderate to severe asthma (Type 2 inflammatory or oral steroid-dependent)
  • Chronic rhinosinusitis with nasal polyps
  • Eosinophilic esophagitis
  • Prurigo nodularis
  • COPD with Type 2 inflammation

How it is administered

Dupixent is administered subcutaneously every two weeks via self-injection at home. Patients are trained on technique and many use auto-injector formulations for convenience.

Patient assistance & support

The manufacturer offers a patient support program — Dupixent MyWay Patient Support — that can help with insurance navigation, copay assistance for eligible patients, nursing support, and ongoing education. More information is available at https://www.dupixent.com/support-savings/myway.

Coordination at Optimed Immunology

Treatment with Dupixent is initiated and monitored by Dr. McNeil. Prior authorizations are handled in-house — patients are not asked to navigate insurance approvals on their own. This is a subcutaneous self-administered medication. After prior authorization, the prescription is sent to a specialty pharmacy that ships the medication directly to the patient. A manufacturer-sponsored nurse or office-based training visit is typically arranged for the first dose so patients are confident with self-administration before continuing at home.

Important safety note: This page is not a substitute for the FDA prescribing information. Risks, contraindications, drug interactions, and required monitoring vary by patient. The official manufacturer website (https://www.dupixent.com) provides the most current full prescribing and safety information. Treatment decisions and monitoring are individualized — please discuss with Dr. McNeil whether Dupixent is appropriate for your situation.

Medically reviewed

Donald L. McNeil, MD · Board Certified in Allergy & Immunology and Internal Medicine

Last reviewed: November 2025 · Sources: FDA prescribing information · manufacturer label · AAAAI · ACAAI · relevant clinical guidelines

This page is provided for educational purposes only and is not medical advice. If you have an emergency, call 911.

Have questions about Dupixent?

Treatment selection is a shared decision. Schedule a consultation with Dr. McNeil to discuss whether Dupixent is appropriate for you.